Omega-3 treatment was associated with significantly fewer gastrointestinal bleeding events for patients with left ventricular assist devices (LVADs), researchers reported in Circulation: Heart Failure.

Higher ejection fractions (EFs) among heart failure patients are associated with an increased incidence of atrial fibrillation (AF) and worse cardiovascular outcomes, according to data from a multinational European registry.

A small-scale pilot study has linked omega-3 fatty acid supplementation to improved social function and reduced cognitive depression in patients with combined chronic heart failure (CHF) and major depressive disorder.

Baylor St. Luke’s Medical Center in Houston has hired two new cardiac surgeons and an administrator in an effort to revamp a heart transplant program that recently lost Medicare funding due to poor patient outcomes, the Houston Chronicle and ProPublica reported.

The HeartMate 3 left ventricular assist device (LVAD) has gained FDA approval for advanced heart failure patients ineligible for a transplant, manufacturer Abbott announced Oct. 19.

Cleveland Clinic researchers identified amyloid deposits in 10.2 percent of patients undergoing carpal tunnel release surgery, suggesting biopsies of hand tissue could be an early signal of life-threatening cardiac amyloidosis.

Women with a history of cardiotoxicity from previous cancer treatments are around 30 percent more likely to experience clinical congestive heart failure (CHF) before, during or after pregnancy, according to research published ahead of print in the Journal of the American College of Cardiology.

Harvard Medical School scientists have created a wirelessly programmed, miniaturized pacemaker which functions for weeks to months at a time, opening the door to “previously impossible investigations of arrhythmia and heart failure in the mouse.”